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1. Introduction 
In its original concept, vaccination aims to mimic the development of naturally acquired 
immunity by inoculation of nonpathogenic but still immunogenic components of the 
pathogen in question, or closely related organisms. Vaccination is one of the most effective 
tools allowing near or complete eradication of fatal diseases. In recent times, vaccination 
was based on conventional approaches that were successful in several diseases but they 
require the pathogen to be grown in laboratory conditions, are time-consuming and allow 
for the identification of only the most abundant antigens, which can be purified in quantities 
suitable for vaccine testing. The conventional approach to vaccine development uses two 
methods: first, attenuation of pathogens by serial passages in vitro to obtain live-attenuated 
strains to be used as vaccines, and second, identification of protective antigens to be used in 
non-living, subunit vaccines.  
Using conventional vaccinology, vaccines targeting pathogens with low antigenic variability 
and those for which protection depends on antibody mediated immunity like polio, MMR, 
Tetanus, Influenza, and Diptheria, had been licensed. Furthermore, if we are dealing with 
non-cultivatable microorganisms or have high antigenic variability or need T cell-dependent 
induced immunity like MenB, TB, HIV, Hepatitis B & C, Malaria and parasite diseases, there 
is no advance to development a specific vaccine. 
With the development of the DNA sequencing technologies in the 1970s till recent years, we 
observed the completion of the sequencing of the genome of humans, a number of 
invertebrate species including Drosophila melanogaster and Caenorhabditis elegans and 
expanding number of microbial pathogens of medical and economic importance (Dalton et 
al., 2003). Expansion of these sequence information developed new approaches to decode, 
analyze and share these massive genetic data. The most widely used term for these 
approaches is the genomics.  
Genomics, studying the genome of organisms as a whole, and postgenomics technologies 
including investigating RNA (transcriptomics), proteins (proteomics), identification of 
immunogenic proteins (immunomics) and metabolites (metabolomics), have had a 
considerable impact in all areas of biological research (Bambini and Rappuoli, 2009), and the 
field of vaccinology is no exception. There are many examples using these approaches to 
develop vaccines but this chapter will focus on the possible genome based approaches to 
confer vaccine developed immunity against two examples of endo- and ecto-parasites such 
as malaria and ticks, respectively. 
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2. Reverse vaccinology 
Genome sequencing is a powerful tool for understanding and controlling infectious 
pathogens. Using this technology, researchers can identify target genes for drug discovery 
and reveal small genetic variations between strains of a specific organism to define its 
virulence and improve the method of control. The approach of reverse vaccinology uses the 
genome sequences of viral, bacterial or parasitic pathogens of interest as starting material 
for the identification of novel antigens, whose activity should be subsequently confirmed by 
experimental biology (Fig. 1) (Rappuoli, 2001). One of the earlier applications of genomics to 
vaccinology (reverse vaccinology) had been the identification of vaccine candidates against 
serogroup B meningococcus by the completion of the whole-genome sequencing (Pizza et 
al., 2000). They had cloned the open reading frames (ORFs) that encode putative virulence 
factors and surface-localized proteins of meningococcus. Several hundred ORFs (350 
surface-exposed protein coding frames) were cloned into expression vectors, purified and 
used to immunize mice. The antibodies binding properties to the products of ORF were 
analyzed using fluorescent activated cell sorter (FACS) analyses and Enzyme linked 
immunosorbent assay (ELISA). The primary vaccine candidates were then tested in vitro 
and/or animal models to provide an insight on the protective efficacy. Twenty nine of these 
surface-exposed proteins were found to be bactericidal. The selected candidates were then 
checked for sequence conservation across a panel of strains representing the genetic 
diversity of meningococcus allowing further selection of antigens capable of eliciting cross-
bactericidal response against the majority of strains included in the panel. 
Reverse vaccinology is based on the high throughput analyses of genome sequences. With 
continuous flow of new genomic sequence and functional annotation data from different 
taxonomic lineages permits scientists to confine correlations depending on the wide range of 
data bases, enabling the design of more reliable analytical and predictive tools. One of the 
most important tools is the alignment of multiple homologous sequences that permitted the 
identification of large number of structural and functional signatures including ligand-
binding sites, sorting signals, protein domain profile, different motifs with catalytic sites and 
more (Vivona et al., 2008). This has generated several integrated databases containing 
combined sets of such signatures and of scanning tools capable of inferring possible 
functions or regulatory mechanisms from the presence of either canonical or degenerate 
signatures in a sequence of interest. Such ‘sequence-to-function’ approaches (Oliver, 1996) 
have enhanced the production of further functional evidence by prediction-driven 
experiments. Early examples included using the identification of specific signatures in a 
sequence to suggest functional assays able to identify otherwise long-sought functions 
(Filippini et al., 1996). They had shown that a plant oncogene rolB from Agrobacterium 
rhizogenes, induces differentiation and growth of neoplastic roots (Hairy-roots) in 
dicotyledonous plants. In addition, the prediction-driven experiments may imply functions 
for disease gene products (Emes and Ponting, 2001, Vacca et al., 2001). Later, more complex, 
genome-wide analyses have led to the identification of proteomic complements that 
underlie regulatory pathways or interaction network organization in model organisms 
(Carpi et al., 2002, Li et al., 2006). 
More recently, bioinformatic approaches are used to uncover functional information and 
enable researchers to tackle biological and biotechnological problems that require the 
integration of diverse strategies of both in silico (on computer) and experimental evidences. 
Besides data analyses, a variety of algorithmic approaches have been used to develop novel 
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tools. The functional potential of these in silico approaches has found its pattern in reverse 
vaccinology.  
Reverse vaccinology presents a revolution in both immunology and biotechnology and 
shows how a biological problem like designing a vaccine could be solved by applying 
integrating tools. However, reverse vaccinology presents a huge advance compared to 
the conventional vaccine production protocols. It takes advantage of the growing 
number of genome sequences available for many organisms. The approach uses 
computer analysis of the genomic sequence to predict suitable candidate vaccine 
molecules. Unfortunately, the approach does not provide certain evidence that the 
selected antigens are either immunogenic or protective. On the contrary, the approach 
permits the identification of novel protein antigens besides the antigens discovered by 
the traditional protocols.  
3. Malaria vaccine research 
Malaria is caused by parasites of the genus Plasmodium of which there are four species that 
infects humans, Plasmodium falciparum, P. vivax, P. ovale and P. malariae. P. falciparum is the 
most fatal and common causative species of malaria in humans. The parasite originally 
develops in the gut of an infected Anopheles mosquito and is passed into humans in the 
saliva of infected mosquitoes. Sporozoites; the pre-erythrocytic stage is transported to the 
liver in the blood or lymph of the human. In the liver, the parasite invades and replicates in 
hepatocytes and after one to two weeks, the sporozoite become mature into thousands of 
merozoites which penetrate the circulating red cells. The replication of the merozoites in 
blood cells causes rapid destruction of blood cells leading to fever and anemia. In the past 
years, antimalarial drugs were the first line of defense in endemic areas but unfortunately, 
there is increasing resistance to these drugs (Wykes and Good, 2007). 
The 500 million new infections each year and 2.5 million annual deaths indicated that all 
measures used so far to control the disease have failed (WHO, 1997, Chaudhuri et al., 2008). 
This world malaria situation had directed researchers to conduct other strategies including 
the identification of only few dozen of malarial proteins (Duffy et al., 2005) by recombinant 
vaccine technology and more than 40 clinical trials were carried out but no vaccine has 
provided a strong and lasting immunity.  
The accessibility of complete genome sequences of Plasmodium falciparum (Gardner et al., 
2002), P. yoelii (Carlton et al., 2002) and P. vivax has provided new opportunity for 
applying the principles of reverse vaccinology. Reverse vaccinology uses bioinformatics in 
the initial steps to identify potential antigens, which are consequently examined for their 
effectiveness and toxicity. The use of algorithm for prediction of subcellular location 
improved the power of identifying potential vaccine candidates (Serruto and Rappuoli, 
2006). Subsequently, developments have been proposed to reverse vaccinology by 
suggesting the use of additional algorithms to find probability of being an adhesin, of 
topology (transmembrane domains) and to find similarity with host protein (Vivona et al., 
2006). Recently, integrative approaches are proposed for reverse vaccinology by including 
prediction of multiple features of proteins such as signal peptides, membrane spanning 
regions, functional motifs and differences in amino acid composition unique to specific 
cellular compartments (Vivona et al., 2008). Implementing this approach, the following 
predictions were included: 
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Fig. 1. Diagrammatic Illustration Summarizing the Vaccine Development Pathway Starting 
from Reverse Vaccinology. (1) First, computer analysis of the entire genome identifies the 
genes coding for predicted antigens and removes those antigens with homologies to human 
proteins. (2) Second, these identified antigens are screened for expression by the pathogen and 
for immunogenicity during infection. (3) Then the selected antigens are used to immunize 
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experimental animals and examine the protective efficacy of immunization. (4) The presence 
and conservation of protective antigens in a collection of strains representative of the species 
(molecular epidemiology), is examined. (5) Finally, large scale production of target antigens 
are manufactured for clinical trials and candidate vaccines are examined for their safety and 
protective immunity in humans. (6) Authorized agencies, such as the Food and Drug 
Administration (FDA), World Health Organization (WHO) or the European Medicinal Agency 
(EMA) analyze and approve the scientific, clinical, and technical information. (7) Policy-
making organizations, such as the Advisory Committee on Immunization Practices (ACIP) 
and equivalent bodies from other nations, prepare the recommendation on how the vaccine 
should be used. (8) In this stage, the approved vaccine is then commercialized and used in 
large scale. At this point, phase IV clinical studies confirm safety. 
3.1 Adhesins 
One of the preventive approaches targets adhesion of parasites to host cells and tissues. 
Adhesion of parasites is mediated by proteins called adhesins. Abrogation of adhesion by 
either immunizing the host with adhesins or inhibiting the interaction using structural 
analogs of host cell receptors holds the potential to develop novel preventive strategies. The 
availability of complete genome sequence offers new opportunities for identifying adhesin 
and adhesin-like proteins. A nonhomology-based approach using 420 compositional 
properties of amino acid dipeptide and multiplet frequencies was used to develop Malarial 
Adhesins and Adhesin-like proteins Predictor (MAAP) Web server with Support Vector 
Machine (SVM) model classifier as its engine for the prediction of malarial adhesins and 
adhesin-like proteins. Several new predictions were obtained. This list includes hypothetical 
protein PF14 0040, interspersed repeat antigen, STEVOR, liver stage antigen, SURFIN, 
RIFIN, stevor (3D7-stevorT3-2), mature parasite-infected erythrocyte surface antigen or P. 
falciparum erythrocyte membrane protein 2, merozoite surface protein 6 in P. falciparum, 
circumsporozoite proteins, microneme protein-1, Vir18, Vir12-like, Vir12, Vir18-like, Vir18-
related and Vir4 in P. vivax, circumsporozoite protein/thrombospondin related anonymous 
proteins, 28 kDa ookinete surface protein, yir1, and yir4 of P. yoelii (Ansari et al., 2008).  
3.2 Paralogs 
It means gene duplication, which have a major role in the evolution of new biological 
functions. Theoretical studies often assume that a duplication per se is selectively neutral and 
that, following a duplication, one of the gene copies is freed from purifying (stabilizing) 
selection, which creates the potential for evolution of a new function (Kondrashov et al., 2002).  
3.3 Transmembrane topologies 
Krogh et al. (2001), predicted a membrane protein topology prediction method; 
transmembrane protein topology with a hidden Markov model (TMHMM). The model is 
based on a hidden Markov model showing that it correctly predicts 97-98 % of the 
transmembrane helices. Additionally, TMHMM can discriminate between soluble and 
membrane proteins with both specificity and sensitivity better than 99 %. The method 
shows that proteins with N(in)-C(in) topologies are strongly preferred in all examined 
organisms, except Caenorhabditis elegans, where the large number of 7TM receptors increases 
the counts for N(out)-C(in) topologies. 
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3.4 β-helix supersecondary structural motifs 
A program named BETAWRAP (http://theory.lcs.mit.edu/betawrap) implements the 
prediction of parallel beta -helices from primary sequences and recognizes each of the 
seven known parallel beta-helix families, when trained on the known parallel beta-helices 
from outside that family. BETAWRAP identifies 2,448 sequences among 595,890 screened 
from the National Center for Biotechnology Information (NCBI; 
http://www.ncbi.nlm.nih.gov/) nonredundant protein database as likely parallel beta-
helices. It identifies surprisingly many bacterial and fungal protein sequences that play a 
role in human infectious disease; these include toxins, virulence factors, adhesins, and 
surface proteins of Chlamydia, Helicobacteria, Bordetella, Leishmania, Borrelia, 
Rickettsia, Neisseria, and Bacillus anthracis. 
3.5 Subcellular localization 
A neural network-based tool, TargetP, for large-scale subcellular location prediction of 
newly identified proteins has been developed. Using N-terminal sequence information only, 
it discriminates between proteins destined for the mitochondrion, the chloroplast, the 
secretory pathway, and “other” localizations with a success rate of 85% (plant) or 90% 
(nonplant) on redundancy-reduced test sets. TargetP is available as a web-server at 
http://www.cbs.dtu.dk/services/TargetP/ (Emanuelsson et al., 2000). 
3.6 Similarity against human proteins 
Using the Basic Local Alignment Search Tool (BLAST) (Altschul et al., 1990). 
3.7 Antigenic regions 
Analysis of data from experimentally determined antigenic sites on proteins reveal that the 
hydrophobic residues Cys, Leu and Val, if they occur on the surface of a protein, are more 
likely to be a part of antigenic sites. The semi-empirical method which makes use of 
physicochemical properties of amino acid residues and their frequencies of occurrence in 
experimentally known segmental epitopes was developed to predict antigenic determinants 
on proteins. Application of this method to a large number of proteins has shown that the 
method can predict antigenic determinants with about 75% accuracy which is better than 
most of the known methods (Kolaskar and Tongaonkar, 1990). 
3.8 Conserved domains 
The conserved domain search results for protein sequences in Entrez are pre-computed to 
provide links between proteins and domain models, and computational annotation visible 
upon request. Protein–protein queries submitted to the BLAST search service are scanned 
for the presence of conserved domains by default (Marchler-Bauer et al., 2005). 
3.9 Epitopes 
The identification of B-cell and T-cell epitopes is a crucial step in peptide vaccine design. 
The experimental scanning of B-cell epitope active regions requires the synthesis of 
overlapping peptides, which span the entire sequence of a protein antigen. This process is 
time consuming and costly. The in silico approaches are the alternative procedures to figure 
out target regions of a protein with possible immunogenic capacity. In this respect, two new 
prediction tools; BcePred and ABCpred servers were developed. BcePred can predict 
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continuous B-cell epitopes, and physic-chemical scales used were hydrophilicity, 
flexibility/mobility, accessibility, polarity, exposed surface, turns and antigenicity. The 
ABCpred was developed to predict continuous or linear B-cell epitopes obtained from 
Bcipep database. This server is based on machine learning techniques (Saha and Raghava, 
2007). 
3.10 Allergens 
The prediction of allergenic proteins is becoming very important due to the use of 
modified proteins in foods (genetically modified foods), therapeutics and bio-
pharmaceuticals. The protein is considered allergen if it has one or more IgE epitopes. 
This kind of prediction can be achieved using the prediction tool created by Saha S, 
Raghava (2006). The predition tool is based on various approaches. First, a standard 
method for predicting allergens based on amino acid and dipeptide composition of 
proteins using support vector machine (SVM). In the second approach, motif-based 
technique has been used for predicting allergens using the software MEME/MAST. Third, 
they assigned a protein as an allergen, if it has a segment similar to allergen 
representative proteins (ARPs). 
4. Data bases and predictive tools in malarial diseases 
A community resource database; MalVac was created. The database is based on data 
analysis of available proteins including 161 adhesin proteins from P. falciparum, 137 adhesin 
proteins from P. vivax and 34 adhesin proteins from P. yoelii. The ORF identification tags 
(ORF ID) assigned to proteins of malaria parasites as given in PlasmoDB 5.4 which is is the 
official database of the Plasmodium falciparum genome sequencing consortium, were used as 
primary keys. The database was developed using MySQL version 4.1.20 at back end and 
operated in Red Hat Enterprise Linux ES release 4. The web interfaces have been developed 
in HTML and PHP 5.1.4, which dynamically execute the MySQL queries to fetch the stored 
data and is run through Apache2 server. The frame of MalVac consists of four basic 
concepts as follows: 
4.1 Motif and topology: includes the transmembrane helices and right handed parallel bata 
helices. 
4.2. Location: the position of the signal peptides and subcellular localization of the 
protein. 
4.3 Immunoinformatics: includes T cell epitopes (MHC class I and II), B cell epitopes 
(conformationaland linear epitopes), Allergens and antigenic regions. 
4.4 Homology: includes the paralogs, orthologs, conserved domains and similarity to host 
proteins. 
The first step towards MalVac database creation is the collection of known vaccine 
candidates and a set of predicted vaccine candidates identified from the whole proteome 
sequences of Plasmodium species provided by PlasmoDB 5.4 release. These predicted 
vaccine candidates are the adhesins and adhesin-like proteins from Plasmodium species, P. 
falciparum, P. vivax and P. yoelii using MAAP server. Subsequently these protein sequences 
will be analysed with 20 algorithms important from the view of reverse vaccinology 
(Table 1). 
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Algorithm Principle Role in MalVac data base 
1. MAAP  Predicts Malarial adhesins and adhesins-like proteins. 
2. BLASTCLUST 
Clusters protein or DNA sequences based on pair wise 
matches found using the BLAST algorithm in case of proteins 
or Mega BLAST algorithm for DNA. Paralogs finding  
3. TMHMM Server v. 2.0  
Predicts the transmembrane helices in proteins based on 
Hidden Markov Model. Transmembrane helices prediction 
4. BetaWrap  
(Betawrap finding) 
Predicts the right-handed parallel beta-helix supersecondary 
structural motif in primary amino acid sequences by using 
beta-strand interactions learned from non-beta-helix 
structures.  
5. TargetP1.1  
(Localization Prediction) 
Predicts the subcellular location of eukaryotic proteins based 
on the predicted presence of any of the N-terminal 
presequences: chloroplast transit peptide (cTP), 
mitochondrial targeting peptide (mTP) or secretory pathway 
signal peptide (SP).  
6. SignalP 3.0  
(Signal Peptide 
Prediction) 
Predicts the presence and location of signal peptide cleavage 
sites in amino acid sequences from different organisms.  
7. BlastP  
It uses the BLAST algorithm to compare an amino acid query 
sequence against a protein sequence database. 
8. Antigenic  
(Antigenic region 
prediction) 
Predicts potentially antigenic regions of a protein sequence, 
based on frequency occurrence of amino acid residue types in 
known epitopes.. 
9. Conserved Domain 
Database 
 (Conserved Domain 
Finding) 
It is used to identify the conserved domains present in a 
protein query sequence.  
10. ABCPred  
(Linear B Cell Epitope 
Prediction) 
Predict B cell epitope(s) in an antigen sequence, using artificial 
neural network. 
11. BcePred 
(Linear B Cell Epitope 
Prediction) 
Predicts linear B-cell epitopes, using physico-chemical 
properties. Linear B Cell Epitope Prediction. 
12. Discotope 1.1  
(Conformational B Cell 
Epitope Prediction) 
Predicts discontinuous B cell epitopes from protein three 
dimensional structures utilizing calculation of surface 
accessibility (estimated in terms of contact numbers) and a 
novel epitope propensity amino acid score.. 
13. CEP 
(Conformational B Cell 
Epitope Prediction) 
The algorithm predicts epitopes of protein antigens with 
known structures.  
14. NetMHC 2.2  
(HLA Class I Epitope 
prediction) 
Predicts binding of peptides to a number of different HLA 
alleles using artificial neural networks (ANNs) and weight 
matrices.  
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Algorithm Principle Role in MalVac data base 
15. MHCPred 2.0 
(MHC Class I and II 
epitope prediction) 
MHCPred uses the additive method to predict the binding 
affinity of major histocompatibility complex (MHC) class I 
and II molecules and also to the Transporter associated with 
Processing (TAP). 
16. Bimas  
(MHC Class I and II 
epitope prediction) 
Ranks potential 8-mer, 9-mer, or 10-mer peptides based on a 
predicted half-time of dissociation to HLA class I molecules. 
The analysis is based on coefficient tables deduced from the 
published literature by Dr. Kenneth Parker, Children's 
Hospital Boston. 
17. Propred 
(MHC Class I and II 
epitope prediction) 
Predicts MHC Class-II binding regions in an antigen 
sequence, using quantitative matrices derived from 
published literature. 
18. AlgPred 
(Allergen Prediction) 
Predicts allergens in query protein based on similarity to 
known epitopes, searching MEME/MAST allergen motifs 
using MAST.  
19. Allermatch 
(Allergen Prediction) 
Predicts the potential allergenicity of proteins by 
bioinformatics approaches as recommended by the Codex 
alimentarius and FAO/WHO Expert consultation on 
allergenicity of foods derived through modern 
biotechnology. 
20. WebAllergen 
(Allergen Prediction) 
The query protein is compared against a set of pre-built 
allergenic motifs that have been obtained from 664 known 
allergen proteins. 
Table 1. Different Algorithms used in MalVac predictions tool: Novel malarial candidate 
vaccines using reverse vaccinology approach. 
5. Ticks 
Ticks are obligate heamatophagous ectoparasite classified in the subclass Acari, order 
Parasitiformes, suborder Ixodida, which are distributed worldwide from the Arctic to 
tropical regions. Ticks include 899 species that parasitize terrestrial vertebrates, including 
amphibians, reptiles, birds and mammals. The three families of ticks include the Argasidae 
or soft ticks (185 species) which is divided into two subfamilies, Argasinae and 
Ornithodorinae, the Ixodidae or hard ticks (713 species ) which is divided into the prostriata 
(Ixodinae; Ixodes) and the Metastriata (subfamilies Amblyomminae,  Haemaphysalinae, 
Hyalomminae and Rhipicephalinae) and the Nuttalliellidae, which only contains one 
species. The recent classification of the genus Boophilus as a subgenus of Rhipicephalus is still 
controversial. 
Ticks, as blood-feeding ectoparasites, affect their hosts both directly and as vectors of viral, 
bacterial and protozoal diseases. Their impact as disease vectors on human wellbeing is 
second only to that of mosquitoes, and their effect on livestock, wildlife and domestic 
animals is immeasurably greater. The veterinary importance of ticks compared to other 
ectoparasites is obvious as they consume large quantities of host blood during their lengthy 
attachment period (7-14 days), which may be extended depending on the tick species and 
unique host association. 
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5.1 Tick genomes 
Ticks have large genomes and their estimated sizes vary from 1.04~7.1 x10(9) bp, about 
one third to over two times the size of the human genome. Karyotype studies have 
revealed a range in chromosome number and the sex determining system seems to be 
primarily driven by a XY or a XO format. Estimates for three species are currently 
available, the smallest being ~109 bp (Amblyomma americanum) and the largest ~7 × 109 bp 
[Rhipicephalus (Boophilus) microplus]; the Ixodes scapularis genome is estimated to be 2 × 109 
bp (Jongejan et al., 2007). 
Nevertheless, sequencing of the genome of I. scapularis is under way. Pilot scale studies on 
the genome of R. (Boophilus) microplus and R. Annulatus are progressing and it is expected 
that this will strengthen a future proposal to sequence the genome more fully. Information 
on ESTs is available for several tick species, including R. (Boophilus) microplus, A. americanum 
and Amblyomma variegatum. Some of these have been used to create a repository of clustered 
and auto-annotated data in the form of species-specific gene indices. 
Ixodes scapularis, the black-legged tick or deer tick, is a hard (ixodid) tick vector of the 
causative agents of Lyme disease, babesiosis and anaplasmosis in the United States. The 
Ixodes genome project was initiated in 2004, and aimed to sequence the genome of a 
medically significant tick. The project represents two important scientific firsts; it is the 
first sequencing project for a tick and a chelicerate. The project is a multi-phase and multi-
investigator undertaking. Current plans call for whole genome shotgun sequencing to 
approximately six fold coverage of the genome. Trace reads from small (2–4 Kbp), 
medium (10–12 Kbp) and large (40–50 Kbp) insert genomic clones will be the basis for 
assembly of the genome sequence. Also included are reads of ~160,000 bacterial artificial 
chromosome (BAC) clone ends (BAC-end sequencing), the complete end-to-end 
sequencing of 60 BAC clones and ~240,000 expressed sequence tag (EST) reads. Paired 
BAC end reads span large segments of the genome and will be used to help assemble 
whole genome shotgun sequence into scaffolds. Sequenced BACs will provide an early 
insight into the Ixodes genome and will have utility as probes for physical mapping of 
assembled sequence to chromosomes. ESTs are arguably one of the most valuable 
resources generated as part of any genome project. These ESTs will be used to identify 
expressed genes, confirm gene predictions and to train automated gene finding 
algorithms. To date, 20 Ixodes BAC clones have been shotgun sequenced and assembled. 
Also available are approximately 370,000 BAC-end reads and more than 80,000 ESTs have 
been sequenced from a normalized pooled stage/tissue library. All sequences have been 
deposited at the National Center for Biotechnology Information (NCBI) (Van Zee et al., 
2007). 
5.2 Tick proteins and proteomics approaches 
The impact of genomics on the knowledge of expressed parasite proteins has barely been 
experienced, yet it is here that genome and gene sequences could have a major, short-term 
impact. Detailed molecular information is available for few proteins from tick-borne 
pathogens and, relatively, for even fewer tick proteins. As an indication of the current 
limitations, for 20 of the most abundantly expressed proteins from unfed R. (Boophilus) 
microplus larvae, only one could be identified from a mass fingerprint alone, whereas 18 
others were tentatively identified through BLAST searches and the limited existing EST 
database, that is, using genomic resources. The importance of translated gene or genome 
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sequences is likely to be even greater for less abundant proteins. Probably the most studied 
tick proteins are those involved in the control of host hemostasis, thought to be critical to the 
success of the feeding tick. 
Hemostasis occurs following vascular injury and comprises three distinct events: vascular 
constriction, platelet aggregation and blood coagulation. Following hemostasis, clot 
dissolution occurs, enabling the resumption of blood flow after tissue repair. Ticks have 
developed a diverse array of anti-hemostatic agents that are considered to be essential for 
successful feeding and tick survival. Ticks circumvent the host defense mechanism 
through the injection of saliva containing large array of bioactive molecule including 
immunomodulators, vasodilators, anticoagulants, inhibitorsof platelet adhesion and 
aggregation and also fibrinolytic and/or fibrinogenolytic agents (Maritz-Olivier et al., 
2007). 
These anti-hemostatics have been found in salivary glands, saliva, eggs and hemolymph, 
appearing not only to prevent blood clot formation in the host, as well as the ingested blood 
meal, but also to regulate hemolymph coagulation in the tick itself. Recently, alternative 
ways to control ticks have been developed, including the employment of anti-tick vaccines 
with either concealed or exposed antigens. Tick anti-hemostatics are predominantly exposed 
antigens because they are secreted from tick salivary glands by regulated exocytosis. The 
importance of these inhibitors to successful tick feeding is exemplified by the finding of 
many such compounds in the tick salivary gland transcriptomes of Ixodes pacificus, Ixodes 
scapularis and Haemaphysalis longicornis. 
A large number of tick anti-hemostatics have been identified, isolated and characterized, 
however, sequence, kinetic and structural data are lacking for the vast majority. 
Examples of the possible hemostatic candidates for vaccine production are summarized 
in (Table 2). 
Current information on tick protein sequences is extremely restricted, limiting the 
application of proteomics. Homology matches have limited usefulness. We urgently need 
more information on the complement of proteins expressed in a variety of tick tissues, life 
stages and species, ideally from more than one species. Sequencing of another tick species 
within the metastriata should be initiated. 
Recent advances in vector biology open new possibilities in target identification and vaccine 
development. The efforts to characterize the genomes of I. scapularis and B. microplus and 
also the current studies implying the use of cDNA libraries of R. annulatus (Shahein et al., 
2008, 2010), R. microplus (Guerrero et al., 2005), A. variegatum (Nene et al., 2002), I scapularis 
(Ribeiro et al., 2006) in the identification of novel molecule, will impact on the discovery of 
new tick-protective antigens. The use of the information in conjugation with functional 
analysis using RNAi, bioinformatics, mutagenesis, transcriptomics, proteomics and other 
technologies will allow for a rapid, systematic approach to tick vaccine discovery by 
addressing the sequencing, annotation and functional analysis. Vaccination trials can be 
designed to evaluate the effect of selected tick antigens in combination with other tick 
protective and pathogen-specific antigens, for improving the level of tick infestations and 
reducing transmission of tick-borne diseases in cattle and other domestic animals. The 
future of research on development of tick vaccines is exciting because of new and emerging 
technologies for gene discovery that facilitate the efficient and rapid identification of 
candidate vaccine antigens. 
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Anti-hemostatic candidate Source Target Molecular 
Mass (kDa) 
Thrombin inhibitors 
 
R. microplus (Boophilin (G2 and H2)) 
Amblyomma variegatum 
R. microplus (Microphilin) 
H. dromedarii NTI-1 
H. dromedarii NTI-2 
Ixodes ricinus Ixin 
 
 
Unknown 
Salivary Glands 
Saliva 
Nymphs 
Nymphs 
Whole tick 
Extract 
 
 
Thrombin 
Thrombin 
Thrombin exosite 1 
Thrombin and FX 
Thrombin and FX 
NI 
 
 
G2=14, H2=14 
NI 
1.8 
3.2 
15 
7 
FX, FXa and Tissue Factor Pathway 
Inhibitors (TFPI) 
 
Ixodes ricinus 
I. scapularis Ixolaris 
 
I. scapularis Salp14 
R. appendiculatus 
 
 
Ornithodoros moubata TAP 
O. savignyi 
 
 
 
 
Whole tick 
Salivary glands 
 
Saliva 
Salivary glands 
 
Salivary glands 
Salivary glands 
 
 
 
FXa 
FX (Heparin binding 
exosite) 
FXa 
FXa, not the active site 
 
FXa 
FXa 
 
 
 
NI 
15.7 
 
14 
65 
 
6 
7 
Uncharacterized intrinsic (INPI) and 
Extrinsic (EXPI) pathway 
 
R. microplus 
H. longicornis HLS1 
O. savignyi BSAP1 
O. savignyi BSAP2 
 
 
 
Eggs, larvae 
Gut 
Salivary glands 
Salivary glands 
 
 
 
INPI, EXPI 
INPI 
EXPI 
EXPI 
 
 
 
NI 
41 
9.3 
9.7 
Kallikrein-Kinin inhibitors 
 
R. microplus 
R. microplus BmTI-D 
R. sanguineus RsTIQ2 
H. longicornis 
 
 
 
Larvae 
Larvae 
Larvae 
Salivary glands 
 
 
NI 
NI 
NI 
FXII, FXIIa and HK 
 
 
18 
8 
12 
16 
Platelet aggregation/Adhesion inhibitors 
 
D. variabilis Variabilin 
O. moubata Moubatin 
O. moubata TAI 
 
 
 
Salivary glands 
Whole tick 
Salivary glands 
 
 
┙IIb┚3 
NI 
┙1┚2 
 
 
5 
17 
15 
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Anti-hemostatic candidate Source Target Molecular 
Mass (kDa) 
Fibrin (ogen) olytic agents 
 
I. scapularis MP1 
I. ricinus Iris 
 
 
 
Salivary glands 
Saliva 
 
 
Fibrin or Fibrinogen 
Elastase 
 
 
36.9 
44 
HK: High molecular weight kininogen; NI: Not Identified; TAI: Tick Adhesion Inhibitor; TAP: Tick 
anticoagulant peptide 
Table 2. Properties of anti-hemostatic molecules from different tick species. 
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